Volume 27, Number 8—August 2021
Research
Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011–2016
Amrei Krings
, Josephine Jacob, Frank Seeber, Uwe Pleyer, Jochen Walker, Klaus Stark, and Hendrik Wilking
, Josephine Jacob, Frank Seeber, Uwe Pleyer, Jochen Walker, Klaus Stark, and Hendrik Wilking
Table 2
Estimated incidence of toxoplasmosis manifestations by year, Germany, 2011–2016
| Disease manifestation | Year | No. patients in database | No. patients identified | Estimated no. patients (95% CI) | Estimated cases/100,000 population (95% CI) |
|---|---|---|---|---|---|
| Ocular toxoplasmosis | 2011 | 4,705,497 | 86 | 1,618 (1,253–2,940) | 2.0 (1.6–3.7) |
| 2012 | 4,751,579 | 95 | 1,937 (1,522–3,189) | 2.4 (1.9–4.0) | |
| 2013 | 5,024,715 | 111 | 2,017 (1,623–3,029) | 2.5 (2.0–3.8) | |
| 2014 | 5,134,795 | 74 | 1,359 (1,015–2,241) | 1.7 (1.3–2.8) | |
| 2015 | 5,177,282 | 76 | 1,452 (1,035–2,342) | 1.8 (1.3–2.9) | |
| 2016 |
5,171,212 |
75 |
1,224 (941–1,931) |
1.5 (1.1–2.3) |
|
| Cerebral toxoplasmosis | 2011 | 4,705,497 | 8 | 144 (56–1,534) | 0.2 (0.1–1.9) |
| 2012 | 4,751,579 | 6 | 114 (40–1,377) | 0.1 (0.1–1.7) | |
| 2013 | 5,024,715 | 5 | 97 (24–1,090) | 0.1 (0.0–1.4) | |
| 2014 | 5,134,795 | 6 | 80 (32–934) | 0.1 (0.0–1.2) | |
| 2015 | 5,177,282 | 13 | 218 (115–970) | 0.3 (0.1–1.2) | |
| 2016 |
5,171,212 |
10 |
200 (74–883) |
0.2 (0.1–1.1) |
|
| Other types of toxoplasmosis† | 2011 | 4,705,497 | 45 | 865 (NA) | NA |
| 2012 | 4,751,579 | 40 | 715 (NA) | NA | |
| 2013 | 5,024,715 | 32 | 588 (NA) | NA | |
| 2014 | 5,134,795 | 58 | 912 (NA) | NA | |
| 2015 | 5,177,282 | 44 | 782 (NA) | NA | |
| 2016 |
5,171,212 |
43 |
651 (NA) |
NA |
|
| Nonspecified types of toxoplasmosis | 2011 | 4,705,497 | 306 | 5,866 (5,093–7,406) | 7.3 (6.3–9.2) |
| 2012 | 4,751,579 | 283 | 5,503 (4,703–6,981) | 6.8 (5.8–8.7) | |
| 2013 | 5,024,715 | 265 | 5,177 (4,483–6,389) | 6.4 (5.6–7.9) | |
| 2014 | 5,134,795 | 237 | 4,277 (3,686–5,327) | 5.3 (4.5–6.6) | |
| 2015 | 5,177,282 | 309 | 5,821 (5,070–6,936) | 7.1 (6.2–8.4) | |
| 2016 |
5,171,212 |
242 |
4,569 (3,862–5,628) |
5.5 (4.7–6.8) |
|
| Congenital toxoplasmosis | 2011 | 97,177 | 10 | 74 (32–1,478) | 0.1 (0.0–1.8) |
| 2012 | 98,140 | 5 | 43 (8–1,321) | 0.1 (0.0–1.6) | |
| 2013 | 100,420 | 10 | 73 (32–1,066) | 0.1 (0.0–1.3) | |
| 2014 | 103,481 | 7 | 77 (16–934) | 0.1 (0.0–1.2) | |
| 2015 | 105,882 | 11 | 116 (41–879) | 0.1 (0.1–1.1) | |
| 2016 |
107,517 |
6 |
65 (25–751) |
0.1 (0.0–0.9) |
|
| Toxoplasmosis during pregnancy | 2011 | 63,102 | 18 | 252 (144–485) | 29.3 (16.7–56.4) |
| 2012 | 53,178 | 14 | 226 (110–478) | 32.0 (15.6–67.7) | |
| 2013 | 53,476 | 16 | 324 (171–619) | 44.4 (23.4–84.9) | |
| 2014 | 52,951 | 21 | 296 (176–560) | 40.5 (24.1–76.6) | |
| 2015 | 53,900 | 21 | 450 (247–803) | 60.3 (33.0–107.5) | |
| 2016 | 37,302 | 14 | 186 (99–431) | 35.3 (18.7–81.7) |
*NA, not available. †Other types include hepatitis, pneumonitis, other organs. Because the number of cases is summarized, no 95% CI and incidence estimation are available.
Page created: June 16, 2021
Page updated: July 18, 2021
Page reviewed: July 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.